_20090817231208.jpg)
Allergan’s Botox Migraine FDA Review Extended 3 Months
August 2nd, 2010
| Tags: aesthetic-medicine, allergan, botox, botox-migraine, business-of-aesthetics, juvederm, migraine, read-more-raquo, restylane
IAPAM News: Aug. 2 (Bloomberg) — Allergan Inc. said U.S
Read the original:
Allergan’s Botox Migraine FDA Review Extended 3 Months
Leave a comment
| Trackback
